What are the recommended treatments for common skin conditions?

Recommended Treatments for Common Skin Conditions

Acne Vulgaris

For acne treatment, multimodal topical therapy combining benzoyl peroxide with a topical retinoid forms the cornerstone of management, with systemic antibiotics or isotretinoin reserved for moderate-to-severe cases. 1

Mild Acne

• Topical retinoids (adapalene, tretinoin, or tazarotene) are strongly recommended as first-line monotherapy for primarily comedonal acne, addressing both microcomedone formation and inflammation 1
• Benzoyl peroxide is strongly recommended and can be used alone or in combination, providing antimicrobial effects without bacterial resistance 1
• Fixed-dose combinations of topical retinoid with benzoyl peroxide are strongly recommended to optimize efficacy 1

Moderate-to-Severe Acne

• Combination therapy with topical retinoid plus benzoyl peroxide plus systemic antibiotics is strongly recommended 1
• Doxycycline 100 mg twice daily is the strongly recommended systemic antibiotic, with minocycline as a conditional alternative 1
• Systemic antibiotics should be limited in duration and always combined with benzoyl peroxide to prevent antibiotic resistance 1
• Topical antibiotics (clindamycin or erythromycin) should never be used as monotherapy due to resistance concerns 1

Severe or Refractory Acne

• Isotretinoin is strongly recommended for severe acne or treatment failures, with patients experiencing psychosocial burden or scarring considered candidates regardless of severity grade 1
• Daily dosing is conditionally recommended over intermittent dosing 1
• Only liver function tests and lipids require monitoring—complete blood counts are unnecessary in healthy patients 1
• Pregnancy prevention is mandatory for persons of childbearing potential 1, 2
• Population-based studies have not identified increased neuropsychiatric or inflammatory bowel disease risks 1

Hormonal Therapy (Adult Females)

• Combined oral contraceptives and spironolactone are conditionally recommended for female patients with acne 1
• Potassium monitoring with spironolactone is unnecessary in healthy patients without risk factors for hyperkalemia 1

Critical Pitfalls

• Avoid topical antibiotic monotherapy—always combine with benzoyl peroxide 1
• Avoid alcohol-containing formulations that worsen dryness 1
• Topical retinoids may cause irritation; mitigate with reduced frequency and concurrent emollients 1
• Benzoyl peroxide causes fabric bleaching and potential contact dermatitis 3

---

EGFR Inhibitor-Induced Skin Reactions

For erlotinib or other EGFR inhibitor-induced rash, initiate topical antibiotics immediately for grade 1 reactions and escalate to systemic tetracyclines for grade ≥2, while maintaining aggressive moisturization throughout. 1, 4

Grade 1 (Mild) Reactions

• Begin topical antibiotics (erythromycin 1%, metronidazole 0.75%, or nadifloxacin 1%) twice daily immediately 1, 4
• Use cream or lotion formulations rather than gels for additional moisturization 1
• Apply moisturizers at least once daily to entire body 1
• Reassess after 2 weeks; if no improvement, escalate to grade 2 management 1

Grade 2-3 (Moderate-to-Severe) Reactions

• Continue EGFR inhibitor therapy while initiating systemic antibiotics 1, 4
• Doxycycline 100 mg twice daily or minocycline 100 mg twice daily for minimum 2 weeks 1
• Continue topical antibiotics and aggressive moisturization 1, 4
• Short-term topical corticosteroids (prednicarbate 0.02% cream) may be added in combination with antibiotics 1
• For grade 3, consider EGFR inhibitor dose reduction per label 1

Essential General Measures

• Use gentle soaps and shampoos exclusively 1, 4
• Apply high SPF sunscreen (SPF 30 or higher) and avoid sun exposure 1, 4
• Maintain clinical follow-up every 2 weeks minimum, with immediate consultation if flare-up occurs 1, 4

Critical Pitfalls

• Never use alcohol-containing gels or solutions—these worsen the inevitable xerosis that develops with EGFR inhibitors 1, 4
• Topical corticosteroids are not recommended as monotherapy 1, 4
• Avoid topical tazarotene and pimecrolimus—randomized trials showed no efficacy 1, 4
• Do not discontinue EGFR inhibitor prematurely—these reactions are effectively treatable at all stages and resolve within 4 weeks of discontinuation if necessary 1, 4

Important Context

• This rash differs from acne vulgaris: skin becomes xerotic (dry) rather than seborrheic, making moisturization essential 1, 4
• Therapeutic benefit typically observed after 3-5 days, with clinically relevant improvement by 1 week 1
• All dermatologic effects are reversible and heal without sequelae 1

---

Congenital Ichthyoses

For congenital ichthyoses, combine daily emollient therapy with keratolytic agents (urea 5-10% or salicylic acid) and consider systemic acitretin for severe forms like lamellar or harlequin ichthyosis. 1

Topical Management

• Apply emollients containing urea (5-10%) or salicylic acid multiple times daily after bathing 1
• Protect fissures with petroleum jelly before applying keratolytics 1
• Manual removal of excess callus may require podiatrist assistance 1

Bathing Protocols

• Daily lukewarm baths for 30 minutes or more are recommended 1
• Use mild soaps or soap-free cleansing bases 1
• Add moisturizing additives, baking soda (3-6 g/L), or normal saline 1
• Gently remove scales with sponges, microfiber cloths, or pumice stone 1
• Antiseptics (chlorhexidine, octenidine 0.1%) should be used 2-3 times weekly only for conditions with recurrent infections 1

Systemic Therapy

• Acitretin is the drug of choice for severe forms (lamellar ichthyosis, harlequin ichthyosis) 1
• Acitretin is especially effective for thick scales and improves hypohidrosis, ectropion, and hearing 1
• Dosage varies between patients and should be prescribed only by experienced dermatologists 1

---

Photoaging Prevention

Daily broad-spectrum sunscreen (SPF 30 minimum) with UVA protection effectively prevents and reverses photoaging when used consistently. 5, 6, 7

Sunscreen Requirements

• Broad-spectrum protection against UVB, UVA, UVA1, visible light, and short infrared (IRA) is required to prevent extrinsic aging 6
• Daily use of SPF 30 broad-spectrum sunscreen significantly improves photoaging parameters (texture, clarity, pigmentation) within 12 weeks 5
• Regular sunscreen use retards skin aging by 24% compared to discretionary use over 4.5 years 7

Additional Photoprotection

• Sunscreens containing antioxidants provide additional benefits against UV, infrared, and pollution-induced oxidative stress 6
• Products containing iron oxide pigments may be required for melasma prevention 6
• No conclusive evidence exists that daily sunscreen compromises vitamin D synthesis 6